02/09/2026
We’re pleased to announce our participation in PFAROS, a new European research and innovation initiative launched to address environmental emissions and exposure concerns related to per- and polyfluoroalkyl substances (PFAS) in the pharmaceutical and medical sectors.
Catherine Vandenborre, Chief Ventures & Corporate Officer, commented: “IBA is pleased to bring its Discovery Lab and Rhodotron® combined expertise’s to the project, with a clear focus on end-of-life and waste-management solutions. By working alongside partners from industry, academia, healthcare and regulatory environments, we aim to contribute to the assessment of robust and scalable technologies that could support a more sustainable future for essential healthcare applications.”
🔗 Read the full press release here: https://www.iba-worldwide.com/iba-joins-pfaros-european-initiative-advance-pfas-destruction-healthcare-and-pharmaceutical